SCRS Resource Guide Network

Sites, Sponsors, CROs: Discover the solutions your clinical research teams need with SCRS.


Leader in Clinical Trial Management Solutions


Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies.

Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory.

Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions.

Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a post-approval research division.


News: Bioclinica blogs 
  • Preparing for Upcoming FDA Guidance on Blood Pressure (BP) Response in Clinical Trials August 31, 2018 10:22am

    — Part 2 in a 3-part blog series on cardiac safety regulatory developments In my last blog, FDA Issues Draft Guidance on Blood Pressure (BP) Response in Clinical Trials, we looked at the FDA's draft guidance Assessment of Pressor Effects of Drugs Guidance for Industry issued in May 2018. In this blog post you'll find answers to commonly asked questions along with additional background and BP safety endpoint considerations to help drug developers prepare for the new FDA BP guidance, which may...
    View this post

  • How Did Trial Supply Optimization Technology Enable Novo Nordisk to Reduce Drug Supply Waste? August 28, 2018 3:33pm

    Despite the high costs associated with either too little drug supply (risking both patient and study outcomes) or too much drug supply (wasting excess or expired drug), as an industry, we have historically been hampered by our ability to accurately forecast how much drug we will need and when and where we will need it. It's a difficult balance to achieve – providing adequate stocks throughout the entire trial while reducing waste – and often results in overstocking to avoid insufficient supp...
    View this post

  • FDA Issues Draft Guidance on Blood Pressure (BP) Response in Clinical Trials August 13, 2018 1:23pm

    Preparing for new BP guidance Part 1 in a 3-part blog series on recent cardiac safety regulatory developments New FDA draft guidance on blood pressure response released in May 2018, entitled: Assessment of Pressor Effects of Drugs Guidance for Industry, is intended to help address blood pressure effect in drug development. If not already familiarized with it, now is a good time to do so as the final guidance — expected to be issued in as early as the first quarter of 2019 — carries importan...
    View this post

  • Achieving True Agile IRT: 5 Questions to Ask Your IRT Vendor July 19, 2018 9:33am

    Although we've largely moved beyond the initial implementation of clinical randomization and supply chain management systems (aka IRT) that were fully customized IT projects for each study to improved processes and more configurability, the industry now demands a more nimble, accurate solution, or "Agile" IRT. To know whether you are truly getting Agile IRT capabilities, it's important to know how to examine a company’s claims around what they are providing. We/I put together five questions th...
    View this post

  • The Future is eSource June 20, 2018 10:21am

    A special guest blog post by Jennifer Price, Senior Director of Clinical Data Management, Paidion Research The many steps, as well as associated labor and time, of manually recording and transcribing clinical trial data into a database are significantly reduced with electronic source data (eSource). Implementing eSource is a single initiative that saves time and money, provides higher quality data, and streamlines your clinical research. Yet, I still often hear from clients that they are reluct...
    View this post

  • Alzheimer's Disease Fluid Biomarkers: Highlights from AAT-AD/PD 2018 Meeting May 31, 2018 11:04am

    The Alzheimer's and Parkinson's Diseases scientific and medical community gathered at the AAT-AD/PD Focus Meeting in March to share the latest research and clinical advances. The event, a new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (AAT) and AD/PDTM, brought new insights on how fluid biomarkers can contribute to Alzheimer's Disease (AD) understanding and diagnosis. Here are some of the key highlights. Certified Reference Material for...
    View this post


  • Bioclinica

    United States
    Map It »
  • Videos1
  • News6
  • Last UpdatedJune 30, 2017 9:21am EDT